NYSE:JNJ Johnson & Johnson (JNJ) News Today $155.06 +0.69 (+0.45%) (As of 05/31/2023 ET) Add Compare Share Share Today's Range$153.85▼$155.6950-Day Range$151.13▼$166.1152-Week Range$150.11▼$183.35Volume10.60 million shsAverage Volume7.66 million shsMarket Capitalization$402.96 billionP/E Ratio32.44Dividend Yield3.07%Price Target$173.00 HeadlinesProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address Play video for Is Johnson & Johnson a Buy in This Market? JNJ Media Mentions By Week JNJ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JNJ News Sentiment▼0.220.79▲Average Medical News Sentiment JNJ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JNJ Articles This Week▼2022▲JNJ Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJ&J faces new trial over talc cancer claims, amid settlement pushca.finance.yahoo.com - May 31 at 8:44 PMObesity Shot Frenzy Makes Eli Lilly World’s Most Valuable Drugmakerfinance.yahoo.com - May 31 at 8:44 PMUPDATE 1-J&J faces new trial over talc cancer claims, amid settlement pushfinance.yahoo.com - May 31 at 8:44 PMJ&J (JNJ) Submits NDA for Single Tablet Combo to Treat PAHfinance.yahoo.com - May 31 at 3:44 PMBristol Myers' (BMY) Lung Cancer Drug NDA Gets Priority Reviewfinance.yahoo.com - May 31 at 3:44 PMThe How and Why of Investing in Biotech Stocks (JNJ)marketbeat.com - May 31 at 1:04 PMBest Of: Inside Johnson & Johnson’s bankruptcy two-stepfinance.yahoo.com - May 31 at 5:44 AMJohnson & Johnson (JNJ) Stock Moves 0.01%: What You Should Knowfinance.yahoo.com - May 30 at 11:31 PMJohnson County program support those with disabilitiesnews.yahoo.com - May 30 at 6:30 PMCitigroup Reiterates Johnson & Johnson (JNJ) Buy Recommendationmsn.com - May 30 at 6:30 PMJohnson & Johnson: The Ultimate Bull Trap Is Heremsn.com - May 30 at 8:30 AMThe Zacks Analyst Blog Highlights InMode, Johnson & Johnson, Intuitive Surgical and GE HealthCarefinance.yahoo.com - May 30 at 8:30 AMJohnson & Johnson (NYSE:JNJ) Now Covered by Citigroupamericanbankingnews.com - May 30 at 8:22 AMJohnson & Johnson (NYSE:JNJ) Seems To Use Debt Quite Sensiblyfinance.yahoo.com - May 29 at 10:49 AMJohnson & Johnson (NYSE:JNJ) Receives $173.00 Consensus PT from Brokeragesamericanbankingnews.com - May 28 at 4:52 AMTylenol-Maker Kenvue Poised to Get Wall Street Ratings After IPOfinance.yahoo.com - May 26 at 5:59 PMMaltin Wealth Management Inc. Sells 1,901 Shares of Johnson & Johnson (NYSE:JNJ)marketbeat.com - May 26 at 2:59 PMA Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.finance.yahoo.com - May 26 at 7:58 AMIs There An Opportunity With Johnson & Johnson's (NYSE:JNJ) 22% Undervaluation?finance.yahoo.com - May 25 at 9:36 AMJohnson & Johnson (JNJ) Stock Moves -0.1%: What You Should Knowfinance.yahoo.com - May 24 at 8:08 PM10 Dementia Medications that are Approved or in Clinical Trialsfinance.yahoo.com - May 24 at 3:07 PMDebt ceiling crisis is already changing market dynamics - what could come next?msn.com - May 23 at 9:25 AMAnalysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and Coherus Biosciences (CHRS)markets.businessinsider.com - May 23 at 9:25 AMSit Investment Associates Inc. Decreases Stock Holdings in Johnson & Johnson (NYSE:JNJ)marketbeat.com - May 23 at 7:18 AMWill Dividends Take Center Stage In The Second Half Of 2023? (JNJ)marketbeat.com - May 23 at 7:01 AMJohnson & Johnson (NYSE:JNJ) Receives Average Rating of "Moderate Buy" from Brokeragesmarketbeat.com - May 23 at 2:32 AMUnusual Put Option Trade in Johnson & Johnson (JNJ) Worth $908.99Kmsn.com - May 23 at 12:32 AMJohnson & Johnson Sees Unusually Large Options Volume (NYSE:JNJ)americanbankingnews.com - May 22 at 9:26 AMJohnson & Johnson (NYSE:JNJ) to Issue Quarterly Dividend of $1.19americanbankingnews.com - May 21 at 8:12 AM3 Relatively Safe Stocks to Buy if a Recession Is on the Wayfinance.yahoo.com - May 20 at 6:59 AMJohnson & Johnson (NYSE:JNJ) Shares Sold by Opus Investment Management Inc.marketbeat.com - May 19 at 7:16 AMJohnson & Johnson (JNJ) Down 2.2% Since Last Earnings Report: Can It Rebound?finance.yahoo.com - May 18 at 1:44 PMJohnson & Johnson (NYSE:JNJ) Coverage Initiated by Analysts at StockNews.comamericanbankingnews.com - May 18 at 7:42 AMShould Income Investors Look At Johnson & Johnson (NYSE:JNJ) Before Its Ex-Dividend?finance.yahoo.com - May 17 at 10:04 AMJohnson & Johnson Sets Aside $400M To End US State Consumer Protection Claimsmsn.com - May 17 at 10:04 AMWhich Pharmaceuticals Stock Is A Better Pick: Johnson & Johnson Or Eliquis’ Maker?forbes.com - May 17 at 10:04 AMRoyal London Asset Management Ltd. Increases Stock Position in Johnson & Johnson (NYSE:JNJ)marketbeat.com - May 17 at 6:46 AMJ&J's proposed talc settlement would pay $400 million to US state AGsca.finance.yahoo.com - May 16 at 3:06 PMWhich Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group?finance.yahoo.com - May 16 at 10:02 AMKenvue Has Gone Public: Should You Buy the Stock?finance.yahoo.com - May 16 at 10:02 AMJohnson & Johnson (NYSE:JNJ) Stock Holdings Increased by Sound View Wealth Advisors Group LLCmarketbeat.com - May 16 at 5:48 AMJohnson & Johnson's (NYSE:JNJ) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?finance.yahoo.com - May 15 at 9:35 AMIs Novavax Finally Turning Things Around? (JNJ)marketbeat.com - May 15 at 8:58 AMUnitedHealth Group is an AI Stock That Isn't Beating Expectations (JNJ)marketbeat.com - May 15 at 8:17 AMJohnson & Johnson (NYSE:JNJ) is Abbrea Capital LLC's 8th Largest Positionmarketbeat.com - May 14 at 5:45 AM25 Best US Cities for People With Allergiesfinance.yahoo.com - May 12 at 11:12 PMSTERIS (STE) Q4 Earnings Beat Estimates, Gross Margin Fallsfinance.yahoo.com - May 12 at 1:10 PMEli Lilly's Market Cap Could Surpass J&J's for First Time Since 1997finance.yahoo.com - May 12 at 1:10 PMEli Lilly on Pace to Top Johnson & Johnson's Market Capfinance.yahoo.com - May 12 at 1:10 PMHow Apple Pleased Investorsfinance.yahoo.com - May 12 at 1:10 PM Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eli Lilly and News Today Merck & Co., Inc. News Today AbbVie News Today Pfizer News Today Bristol-Myers Squibb News Today Novo Nordisk A/S News Today AstraZeneca News Today Novartis News Today Abbott Laboratories News Today Sanofi News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NYSE:JNJ) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.